Xylem Inc.
—- Market cap
- —
- Debt
- +$2.49B
- Cash
- −$1.48B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: XYL stock price vs TXT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TXT's multiple
Needs TXT P/E.
Implied fair value · at XYL's multiple
Needs XYL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Xylem Inc. · implied price per share
Bear
$36.50
Base
$43.66
Bull
$52.98
Textron Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
DANAHER CORP /DE/
XYL vs DHR
IDEX CORP /DE/
XYL vs IEX
PENTAIR plc
XYL vs PNR
ECOLAB INC.
XYL vs ECL
FLOWSERVE CORP
XYL vs FLS
DOVER Corp
XYL vs DOV
BOEING CO
XYL vs BA
LOCKHEED MARTIN CORP
XYL vs LMT
NORTHROP GRUMMAN CORP /DE/
XYL vs NOC
Howmet Aerospace Inc.
XYL vs HWM
CURTISS WRIGHT CORP
XYL vs CW
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe XYL can sustain its superior margins and justify a premium multiple despite slower revenue growth, then hold or accumulate selectively; otherwise, reduce exposure because the current price implies -44.1% downside to the P/E-based value and sits above the DCF range.
XYL’s current price of $116.97 implies a -44.1% downside versus the $65.40 P/E-derived value, indicating a large valuation premium relative to TXT. The premium is partly supported by XYL’s stronger profitability profile, but the gap is still wide versus both model output and TXT valuation.
Supporting Metrics